InvestorsHub Logo
Followers 72
Posts 4827
Boards Moderated 0
Alias Born 01/24/2004

Re: entdoc post# 78042

Tuesday, 04/03/2012 12:20:52 PM

Tuesday, April 03, 2012 12:20:52 PM

Post# of 346164
EntDoc, in case U missed it, as ref'd towards the end of today's PS-Imaging PR, they've added a separate webpage for PS-Imaging:
http://www.peregrineinc.com/technology/ps-imaging.html
...as well as a PS-Imaging DATA page:
http://www.peregrineinc.com/technology/ps-imaging/ps-imaging-data.html

= = = = = = = = = = = =
About 124I-PGN650:
124I-PGN650 is a first-in-class phosphatidylserine (PS)-targeting F(ab')(2) fully human monoclonal antibody fragment joined to the PET imaging radio-isotope iodine-124 (124I) that represents a new approach to imaging cancer. PS is a molecule usually located inside the membrane of healthy cells, but "flips" and becomes exposed on the outside of cells that line tumor blood vessels, creating a specific target for the imaging of multiple solid tumor types. In preclinical studies, 124I-PGN650 accumulates in tumor vasculature and provides exceedingly clear in vivo tumor images.
4-3-12: "…with the recent filing of an Investigational New Drug application with the U.S. FDA. [for a 12-pt. 124I-PGN650 Imaging Trial]"
http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=661456
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News